Literature DB >> 485681

Studies on the effects of anti-inflammatory action of benzoyl-hydrotropic acid (ketoprofen) and other drugs, with special reference to prostaglandin synthesis.

T Kubota, H Komatsu, H Kawamoto, T Yamada.   

Abstract

Effects of ketoprofen, indomethacin, phenylbutazone and acetylsalicylic acid on edema and on in vivo and in vitro synthesis of PGE1, PGE2 and PGF2 alpha in response to carrageenin were studied in rats. Ketoprofen was a potent drug in depressing edema and increased PGE1, PGE2 and PGF2 alpha in response to carrageenin. Ketoprofen also inhibited in vitro synthesis of PGE2 and PGF2 alpha from arachidonic acid. The relative potency of ketoprofen in those parameters was comparable to or greater than that of indomethacin. Phenylbutazone and acetyl-salicylic acid were, however, less potent in this respect. It is suggested that ketoprofen manifests its anti-inflammatory action, at least in part, by inhibiting prostaglandin synthesis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 485681

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  5 in total

Review 1.  Chirality and nonsteroidal anti-inflammatory drugs.

Authors:  P J Hayball
Journal:  Drugs       Date:  1996       Impact factor: 9.546

2.  Hypotensive activity of PAF-acether in rats.

Authors:  C G Caillard; S Mondot; J L Zundel; L Julou
Journal:  Agents Actions       Date:  1982-12

3.  Clinical pharmacokinetics of ketoprofen after single intravenous administration as a bolus or infusion.

Authors:  D Debruyne; B Hurault de Ligny; J P Ryckelynck; F Albessard; M Moulin
Journal:  Clin Pharmacokinet       Date:  1987-03       Impact factor: 6.447

4.  Efficacy of ketoprofen in treating primary dysmenorrhea.

Authors:  S Gleeson; J Sorbie
Journal:  Can Med Assoc J       Date:  1983-10-15       Impact factor: 8.262

5.  Pharmacokinetics and Pharmacodynamics of (S)-Ketoprofen Co-Administered with Caffeine: A Preclinical Study in Arthritic Rats.

Authors:  Raúl Medina-López; Nancy Vara-Gama; Olivia Soria-Arteche; Luis A Moreno-Rocha; Francisco J López-Muñoz
Journal:  Pharmaceutics       Date:  2018-01-26       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.